XOMA Royalty (XOMA) Depreciation & Amortization - Total (2024 - 2026)

XOMA Royalty's (XOMA) quarterly Depreciation & Amortization - Total came in at $3000.0 in Q1 2026, little changed year-on-year from $3000.0 in Q1 2025, and little changed quarter-over-quarter from $3000.0 in Q4 2025.

XOMA Royalty (XOMA) Depreciation & Amortization - Total (2024 - 2026) Analysis & Trends

XOMA Royalty has disclosed Depreciation & Amortization - Total across 3 years of filings, most recently posting $3000.0 for Q1 2026.

  • Depreciation & Amortization - Total for Q1 2026 came in at $3000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $11000.0 (changed 0.0% YoY), and the FY2025 annual result was $11000.0, up 10.0% from the prior year.
  • Depreciation & Amortization - Total came in at $3000.0 for Q1 2026 at XOMA Royalty, roughly flat from $3000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization - Total ranged from a high of $3000.0 in Q2 2024 to a low of $2000.0 in Q1 2024.
  • The 3-year median for Depreciation & Amortization - Total is $3000.0 (2024), against an average of $2666.7.
  • Peak annual rise in Depreciation & Amortization - Total reached 50.0% in 2025, while the deepest fall reached 33.33% in 2025.
  • XOMA Royalty's Depreciation & Amortization - Total stood at $2000.0 in 2024, then surged by 50.0% to $3000.0 in 2025, then changed by 0.0% to $3000.0 in 2026.
  • The last three Depreciation & Amortization - Total figures came in at $3000.0 (Q1 2026), $3000.0 (Q4 2025), and $2000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Tot) (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn -
9 Abivax 91.71 Bn 91.71 Bn - -
10 XOMA Royalty 5.48 Mn -60.60 Mn - 3,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 3,000.00
Dec 31, 2025 3,000.00
Sep 30, 2025 2,000.00
Jun 30, 2025 3,000.00
Mar 31, 2025 3,000.00
Dec 31, 2024 2,000.00
Sep 30, 2024 3,000.00
Jun 30, 2024 3,000.00
Mar 31, 2024 2,000.00